Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Inhaled Salbutamol on Sprint Performance in Non-asthmatic Athletes
NCT04402658Withdrawn
- Sponsor
- Norwegian School of Sport Sciences
- Start
- Aug 2022
- Primary completion
- May 2023
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial in asthma comparing Salbutamol with Placebo (2 arms). Primary endpoints: Anaerobic performance at 30 minutes and Sprint performance at 60 minutes. Planned start Aug 2022; status: withdrawn.
02
Drugs
salbutamol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT04402658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04402658.